News

Mr Khiang is a co-founder, partner and director of multiple investment companies, including Evia Capital Partners and Evia Growth Opportunities since 2004, and has been a director of

Sinobiopharma is reportedly the world’s first manufacturer and marketer of Perindopril in capsule form. The company’s patent application covers the method of preparation and stability for new drug

Under the terms of the collaboration, Millennium will pay a $4 million upfront fee for an exclusive antibody-drug conjugate (ADC) license to an initial antigen expressed on solid

Bristol-Myers Squibb and AstraZeneca have reported that the FDA’s endocrinologic and metabolic drugs advisory committee determined that the data supporting the new drug application for Onglyza for the

Preclinical studies of CryoLife’s BioFoam surgical matrix, a protein hydrogel product under development for organ sealing, are nearing completion. This grant will help fund upcoming clinical studies of

Dr Kirchrath was most recently European pharmaceutical district manager for Affymetrix where he developed targeted sales and business development strategies, and managed cross-functional workflows between sales, marketing, field

Takeda Pharmaceutical Company and its wholly-owned UK-based subsidiary for overseeing pan-European sales and marketing, Takeda Pharmaceutical Europe have started sales and marketing operations in Spain, and have also

IntelGenx and Cary Pharma have previously entered into a collaborative agreement to jointly develop and commercialize CPI-300 using IntelGenx’s oral delivery technology. Under the terms of the collaborative

Mr Cotter spent 10 years as the vice president of operations for Closure Medical, a medical device company, acquired by Johnson & Johnson. Prior to Closure Medical, Mr